13. intrahepatic cholestasis of pregnancy3rd jun 15
TRANSCRIPT
BY:
PAWA N K B A GR AWA LR E S I D E N T M D G P, Y E A R I I , I OM M A H A R A J GU N J .
2 N D J U N E , 2 0 1 5 .MO D E R AT OR : D R . R A J E S H A D H I K A R I
INTRAHEPATIC CHOLESTASIS OF
PREGNANCY
OUTLINE
• Rationale• Introduction• Epidemiology• Risk factors• Pathogenesis• Clinical presentation• Differentials• Investigations• Morbidity/Mortality• Management• Implications• Conclusion
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
2
RATIONALE
• It is the most common pregnancy related liver disorder (1).
• Approximately 1 % of pregnancies in the U.S. are complicated by this condition while the prevalence is approximately double in South Asia region (2).
• Tricky. Maternal outcomes are often good. However, fetal outcomes may be devastating.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
3
INTRODUCTION
• Also known as icterus gravidarum, cholestatic hepatosis & recurrent jaundice of pregnancy.
• Defined as reversible type of hepatic dysfunction induced by hormonal changes in late pregnancy & clinically characterized by generalized pruritis often commencing on palms & soles in absence of visible skin lesions.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
4
EPIDEMIOLOGY
• Common in South Asia, South America & the Scandinavian countries (1).
• High incidence in Latin America . 4% in Chile (4).
• Has seasonal variation. More frequent in winters (1).
• Appears in late second trimester or third trimester secondary to peak in estrogen concentrations.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
5
RISK FACTORS
• Advanced maternal age.• History of cholestasis with COC.• Multiple pregnancies.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
6
PATHOGENESIS
Genetic Susceptibility. ABCB 4 gene
Inadequate excretion of bile salts : inhibition of hepatocellular bile salt
export pumps or saturation by sulfated progesterone metabolites
Increased serum bile salts : taurocholate & taurodeoxycholate.
Deposition in skin
Intense pruritis
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
7
CLINICAL PRESENTATION
• Generalized pruritis starting from the palms & soles progressing to trunk & face.
• Skin lesions often absent and limited to excoriations.
• Worse at night.• Only 10% develop jaundice (3). Typically
develops 1-4 weeks after onset of itching (1) .
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
8
DIFFERENTIALS
1. Pruritis gravidarum2. Choledocholithiasis3. Preeclampsia4. Dermatoses
1. Pemphigoid gestationis2. Pruritic urticarial papules and plaques of pregnancy3. Atopic eruption of pregnancy 4. Pustular psoriasis of pregnancy
5. Viral hepatitis6. Acute fatty liver of pregnancy
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
9
DIFFERENTIALS
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
10
DIFFERENTIALS
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
11
DIFFERENTIALS
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
12
DIFFERENTIALS
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
13
INVESTIGATIONS
• LFTs (3)• For transaminases,gamma-glutamyl transferase and
bilirubin, the upper limit of normal throughout pregnancy is 20% lower than the non-pregnant range (6).
• Serum aminotransferase levels are normal to moderately elevated and seldom exceed 250 U/L.
• Conjugated hyperbilirubinemia with total bilirubin often less than 4-5 mg/dl .
• Alkaline phosphatase is increased up to 4 fold (1).• PT reflects Vit K status.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agraw
al14
INVESTIGATIONS
• Viral screen • Hepatitis A, E, B & C• EBV &• CMV
• USG abdomen• To rule out choledocholithiasis• Obstetric scan for fetal well being.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agraw
al15
INVESTIGATIONS
• Bile acid levels (1)• The most sensitive & specific marker of ICP.• Total serum bile acid level greater than 10 μmol/L.• The cholic acid level is significantly increased while the
chenodeoxycholic acid level is mildly increased.
• Liver biopsy• Not recommended• Shows bile plugs without evidence of inflammation and
bile pigment in hepatocytes.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
16
MORBIDITY/ MORTALITY
• Rook and colleagues (2012) reported outcomes of 101 affected women in Northern California.
• Although there were no term fetal demises, 87percent of women underwent labor induction.
• Neonatal complications occurred in a third of the pregnancies, particularly respiratory distress, fetal distress, and meconium-stained amniotic fluid, all of which were reported more frequently with higher total bile acid levels.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
17
MORBIDITY/ MORTALITY
• Fetal:• The risk of fetal demise range from 2-11% .But
rarely occurs prior to 36 weeks of gestation (1). Increased risk with bile acids >40 μmol/L or presence of jaundice. (Attributed to 1) transfer of bile acids across placenta, into cardiomyocytes & causing arrythmias 2) fetal anoxia & 3) vasoconstriction of chorionic veins)
• Preterm delivery (mostly due to surgeon’s distress and spontaneous ones have been hypothesized due to increased myometrial contractions sec to bile salt depositions)
• Fetal distress & meconium staining of liquor in a third of affected pregnancies (3).
• Neonatal respiratory distress (bile salt deposition in fetal lungs).
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
18
MORBIDITY/ MORTALITY
• Maternal:• Steatorrhoea• Vitamin K deficiency• PPH 2-22% (6) otherwise 4-6%.• Cholestasis recurs in 60-70% of subsequent
pregnancies with variable severity.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
19
MANAGEMENT
• Concerns:• sudden fetal death ,• PPH & • maternal discomfort.
• Supportive: • Antihistaminics like cetirizine (cat B) and
topical emmolients can be used for symptomatic relief but not much effective.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
20
MANAGEMENT
• Cholestyramine (8-16 g/day) has also been used but causes further reduction in absorption of fat soluble vitamins.
• Dexamethasone (10 mg OD for 7 days followed by tapering over 3 days)
• Ursodeoxycholic acid starting at daily doses of 300mg TDS has been the drug of choice. Improves both clinical & lab parameters. ? Better fetal outcome.
• Vit K in cases of prolonged PT
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
21
MANAGEMENT
• Monitoring:• Umbilical artery doppler twice-weekly superior
to NST .• LFTs repeated weekly until delivery.
• Definite:• Termination of pregnancy with induction at
37 weeks or prior to 37 weeks in cases of excruciating & unremmitting pruritis after confirmation of lung maturity.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
22
MANAGEMENT
• Follow up:• Postnatal resolution of symptoms and of
biochemical abnormalities is required to secure the diagnosis.
• Postnatal resolution of symptoms and of biochemical abnormalities is required to secure the diagnosis. Repeat LFT once in postnatal follow up beyond 10 days.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
23
IMPLICATIONS/ASSOCIATIONS
• CDC considers combined pills appropriate in women with ICP.
• Affected women are at increased risk of developing gall stones
• Women with persistent pruritis and normal LFTs should have it repeated every one to two weeks.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
24
CONCLUSION
• ICP is a diagnosis of exclusion.• Good maternal outcome. Fetal outcome may
be devastating.• Genetic predisposition.• UDCA is the first line treatment.• Imperative to terminate pregnancy at 37
weeks.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
25
REFERENCES
1. Rigby FB. Intrahepatic cholestasiss of pregnancy. 2015; Available at: URL:http://emedicine.medscape.com/article/1562288-overview#showall. Accessed May 22, 2015.
2. James D. High risk pregnancy management options. 4th ed. Saunders; 2000.
3. Cunnigham et al . Williams obstetrics. 24th ed . Mac Graw Hill ; 2014.
4. Dutta D.C. Textbook of obstetrics. 7th ed. New Central Book Agency ; 2010.
5. Bacq Y, Lee RH. Cholestasis of pregnancy. 2011; Available at: URL:http://UpToDate19.3/contents/mobipreview.htm?15/62/16352#H1
6. Kenyon AP. Obstetric cholestasis. RCOG Green-top Guideline No. 43.
3-JUN
-15Intrahepatic Cholestasis of Pregnancy by Paw
an KB Agrawal
26